Clincosm LogoSign in Get a demo

Advanced Malignancies

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignancies, Metastatic Cancer Trial in Worldwide (INCAGN01876, Nivolumab, Ipilimumab)

Completed
Has Results
  • Advanced Malignancies
  • Metastatic Cancer
  • Los Angeles, California
  • +37 more
Dec 6, 2022

Recurrent Cancer, Metastatic Cancer, Advanced Malignancies Trial (INCAGN01876, retifanlimab)

Recruiting
  • Recurrent Cancer
  • +3 more
  • INCAGN01876
  • retifanlimab
  • Birmingham, Alabama
  • +17 more
Dec 13, 2022

Solid Tumors, Advanced Malignancies, Metastatic Cancer Trial in United States (INCB052793, gemcitabine, nab-paclitaxel)

Terminated
Has Results
  • Solid Tumors
  • +2 more
  • Birmingham, Alabama
  • +13 more
Apr 6, 2020

Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,

Completed
  • Advanced Cancer
  • Advanced Malignancies
  • Gilbert, Arizona
  • +46 more
Jan 23, 2020

Advanced Malignancies Trial in United States (MEDI0680 (AMP-514))

Completed
  • Advanced Malignancies
  • MEDI0680 (AMP-514)
  • New Haven, Connecticut
  • +5 more
Oct 4, 2017

Advanced Malignancies Trial in United States (REGN2810)

Withdrawn
  • Advanced Malignancies
  • Duarte, California
  • +8 more
Nov 4, 2016

Advanced Malignancies Trial in United States (CDX-1401 in combination with Resiquimod and/or Poly-ICLC, CDX-1401, Resiquimod)

Completed
  • Advanced Malignancies
  • CDX-1401 in combination with Resiquimod and/or Poly-ICLC
  • +3 more
  • New Haven, Connecticut
  • +6 more
Jun 22, 2016